![Seong-Cheol Park](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Seong-Cheol Park
Direktor/Vorstandsmitglied bei
Curiox Biosystems, Inc.
Vermögen: 678 537 $ am 30.09.2026
Profil
Seong-Cheol Park is currently Director at Curiox Biosystems Pte Ltd. and Curiox BioSystems, Inc. Formerly, Director at Curiox Biosystems Co., Ltd. Educated at Korea Advanced Institute of Science & Technology with undergraduate and graduate degrees.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.08.2026 | 16.000 ( 0,09 % ) | 678 537 $ | 30.09.2026 |
Aktive Positionen von Seong-Cheol Park
| Unternehmen | Position | Beginn |
|---|---|---|
Curiox Biosystems, Inc.
 Curiox Biosystems, Inc. Medical SpecialtiesHealth Technology Curiox Biosystems is a company that specializes in developing innovative technologies for life science research, diagnostics, and therapeutics discovery and development. The company was spun out of the Agency for Science, Technology, and Research (A*Star) and brings together decades of scientific and engineering expertise in surface chemistry and life science instrumentation. Curiox Biosystems' focus is on developing technologies that improve productivity and data quality by focusing on common assay steps where miniaturization and automation are currently underutilized. The aim is to simplify sample preparation while improving data quality and workflow, and to accelerate high-throughput flow and mass cytometry workflows with fully automated sample preparation. The Laminar Wash technology systems delivered by Curiox Biosystems are faster and easily automated, delivering higher quality data through better cell retention, improved preservation of cellular physiology and viability, exceptional study-to-study and operator-to-operator reproducibility. The company is based in Woburn, MA. The company was founded in 2008. The CEO is Namyong Kim. | Direktor/Vorstandsmitglied | - |
Curiox Biosystems Pte Ltd.
 Curiox Biosystems Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Develops innovative assay platforms | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Seong-Cheol Park
| Unternehmen | Position | Ende |
|---|---|---|
| CURIOX BIOSYSTEMS CO., LTD | Direktor/Vorstandsmitglied | - |
Ausbildung von Seong-Cheol Park
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
7
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Korea Advanced Institute of Science & Technology
 Korea Advanced Institute of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Curiox Biosystems Pte Ltd.
Curiox Biosystems Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Develops innovative assay platforms | Commercial Services |
Curiox Biosystems, Inc.
Curiox Biosystems, Inc. Medical SpecialtiesHealth Technology Curiox Biosystems is a company that specializes in developing innovative technologies for life science research, diagnostics, and therapeutics discovery and development. The company was spun out of the Agency for Science, Technology, and Research (A*Star) and brings together decades of scientific and engineering expertise in surface chemistry and life science instrumentation. Curiox Biosystems' focus is on developing technologies that improve productivity and data quality by focusing on common assay steps where miniaturization and automation are currently underutilized. The aim is to simplify sample preparation while improving data quality and workflow, and to accelerate high-throughput flow and mass cytometry workflows with fully automated sample preparation. The Laminar Wash technology systems delivered by Curiox Biosystems are faster and easily automated, delivering higher quality data through better cell retention, improved preservation of cellular physiology and viability, exceptional study-to-study and operator-to-operator reproducibility. The company is based in Woburn, MA. The company was founded in 2008. The CEO is Namyong Kim. | Health Technology |
Curiox Biosystems Co., Ltd.
 Curiox Biosystems Co., Ltd. Packaged SoftwareTechnology Services Develops bio equipment technology company | Technology Services |
